Skip navigation
Skip navigation

Menopausal hormone therapy use and breast cancer risk in Australia: Findings from the New South Wales Cancer, Lifestyle and Evaluation of Risk study

Salagame, Usha; Banks, Emily; Sitas, Freddy; Canfell, Karen


Randomised controlled trials and large-scale observational studies have found that current use of menopausal hormone therapy (MHT) is associated with an increased risk of breast cancer; this risk is higher for oestrogen–progestagen combination therapy than for oestrogen-only therapy. Our study was designed to estimate MHT-associated breast cancer risk in a population of Australian women. Data were analysed for postmenopausal women with self-reported incident invasive breast cancer (n = 1,236)...[Show more]

CollectionsANU Research Publications
Date published: 2016
Type: Journal article
Source: International Journal of Cancer
DOI: 10.1002/ijc.29942


File Description SizeFormat Image
01_Salagame_Menopausal_hormone_therapy_use_2016.pdf367.85 kBAdobe PDF    Request a copy

Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  22 January 2019/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator